Dublin, Feb. 13, 2017 -- Research and Markets has announced the addition of the "The Top 300 Manufacturers of In-Vitro Diagnostics Products Worldwide" report to their offering.
This unique and comprehensive report profiles the top 300 manufacturers of in-vitro diagnostics products worldwide. These global leaders are continually developing new and innovative products to add to their already comprehensive core laboratory, point-of-care and molecular diagnostics portfolios. They are located from the United States and Europe to India and China and have highly effective commercial networks.
Profile information for each company in The Top 300 Manufacturers Of In-Vitro Diagnostics Products Worldwide' typically includes:
- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, Products, Clinical Specialties/Diseases, Year Established, Number of Employees, Revenue and Ownership.
Report Target Market:
1) IVD Manufacturing Companies
Usage: competitive/financial analysis and strategic partner/alliance identification
2) IVD Suppliers
This report is perfect for suppliers of goods and services such as components and sub-assemblies and development, design and manufacturing services to identify top potential customers.
3) IVD Distributors
The Top 300 Manufacturers Of In-Vitro Diagnostics Products Worldwide' is very useful to IVD distributors to identify the leading manufacturers with the best products.
4) Industry Associations
This report is a useful reference tool for IVD Industry Associations.
Report data field structure is as follows:
- Company Name
- Address
- Telephone
- Fax
- Email
- Website
- Year Established
- Number of Employees
- Key Executives
- Company Description
- Products
- Clinical Specialties/Diseases
- Revenue ($U.S. million)
- Location Status
- Ownership
- Stock Exchange/Ticker Symbol
- Parent Company
For more information about this report visit http://www.researchandmarkets.com/research/ph4rvb/the_top_300
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



